Moderna Cancer Treatment Shows Promise in Clinical Trial

Why it matters locally: While the clinical trial results are national in scope, advancements in cancer treatment could eventually benefit patients across Ohio. The development of personalized mRNA-based therapies holds potential for improved outcomes in various medical facilities throughout the state.

---

Moderna's shares increased after the company announced positive results for its experimental mRNA-based cancer treatment. The therapy, called intismeran, is under development in collaboration with Merck. Researchers designed intismeran to be customized for individual patients. It targets specific mutations found within each patient's tumor.